Literature DB >> 14803638

The dependence of the pathological lesion upon the multiplication of pneumonia virus of mice (PVM); kinetic relation between the degree of viral multiplication and the extent of pneumonia.

F L HORSFALL, H S GINSBERG.   

Abstract

The rate of multiplication of PVM in the mouse lung is relatively constant, averaging 7.9-fold per day with but slight variations, irrespective of the amount of virus inoculated. Similarly, the rate of increase in the amount of pneumonia is relatively constant, averaging 4.7-fold per day, even though the quantity of virus inoculated is varied over a wide range. It follows that viral multiplication proceeds 1.7 times more rapidly than does extension of the pathological lesion, both reaching limiting maximal values in periods which are predictable from the amount of virus inoculated. From the concentration of virus determined at any time during the incremental period, the amount of pneumonia present earlier or later in the incremental period can be computed with considerable precision. The results support the postulate that the extent of the pathological lesion is dependent upon the degree of viral multiplication.

Entities:  

Keywords:  PNEUMONIA, VIRAL; VIRUSES

Mesh:

Year:  1951        PMID: 14803638      PMCID: PMC2136061          DOI: 10.1084/jem.93.2.139

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  Characteristics of the multiplication cycle of pneumonia virus of mice (PVM).

Authors:  H S GINSBERG; F L HORSFALL
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307

2.  Therapy of infection with pneumonia virus of mice (PVM); effect of a polysaccharide on the multiplication cycles of the virus and on the course of the viral pneumonia.

Authors:  H S GINSBERG; F L HORSFALL
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307

3.  NEUTRALIZATION OF EPIDEMIC INFLUENZA VIRUS : THE LINEAR RELATIONSHIP BETWEEN THE QUANTITY OF SERUM AND THE QUANTITY OF VIRUS NEUTRALIZED.

Authors:  F L Horsfall
Journal:  J Exp Med       Date:  1939-07-31       Impact factor: 14.307

4.  STUDIES ON PNEUMONIA VIRUS OF MICE (PVM) : III. HEMAGGLUTINATION BY THE VIRUS; THE OCCURRENCE OF COMBINATION BETWEEN THE VIRUS AND A TISSUE SUBSTANCE.

Authors:  E C Curnen; F L Horsfall
Journal:  J Exp Med       Date:  1946-01-31       Impact factor: 14.307

5.  A LATENT VIRUS IN NORMAL MICE CAPABLE OF PRODUCING PNEUMONIA IN ITS NATURAL HOST.

Authors:  F L Horsfall; R G Hahn
Journal:  J Exp Med       Date:  1940-02-29       Impact factor: 14.307

6.  STUDIES ON PNEUMONIA VIRUS OF MICE (PVM) : I. THE PRECISION OF MEASUREMENTS IN VIVO OF THE VIRUS AND ANTIBODIES AGAINST IT.

Authors:  F L Horsfall; E C Curnen
Journal:  J Exp Med       Date:  1946-01-01       Impact factor: 14.307

7.  CENTRIFUGATION STUDIES ON PNEUMONIA VIRUS OF MICE (PVM) : THE RELATIVE SIZES OF FREE AND COMBINED VIRUS.

Authors:  E C Curnen; E G Pickels; F L Horsfall
Journal:  J Exp Med       Date:  1947-01-01       Impact factor: 14.307

8.  STUDIES ON PNEUMONIA VIRUS OF MICE (PVM) : II. IMMUNOLOGICAL EVIDENCE OF LATENT INFECTION WITH THE VIRUS IN NUMEROUS MAMMALIAN SPECIES.

Authors:  F L Horsfall; E C Curnen
Journal:  J Exp Med       Date:  1946-01-01       Impact factor: 14.307

  8 in total
  16 in total

1.  The nature of viral inclusion bodies and their differentiation from non-viral inclusions.

Authors:  M WOLMAN
Journal:  Experientia       Date:  1955-01-15

2.  The growth of micro-organisms in vivo with particular reference to the relation between dose and latent period.

Authors:  G G MEYNELL; E W MEYNELL
Journal:  J Hyg (Lond)       Date:  1958-09

3.  Virus reproduction and virus disease.

Authors:  F L HORSFALL
Journal:  Can Med Assoc J       Date:  1955-11-15       Impact factor: 8.262

4.  Characteristics on the adenoviruses. III. Reproductive cycle of types 1 to 4.

Authors:  H S GINSBERG
Journal:  J Exp Med       Date:  1958-01-01       Impact factor: 14.307

5.  Suppression of certain viral lesions by a microbial product, xerosin, lacking in demonstrable antiviral properties and produced by Achromobacter xerosis, n. sp.

Authors:  V GROUPE; L H PUGH; A S LEVINE; E C HERRMANN
Journal:  J Bacteriol       Date:  1954-07       Impact factor: 3.490

6.  Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus.

Authors:  J M Torres; C Alonso; A Ortega; S Mittal; F Graham; L Enjuanes
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Comparative effects of hydrocortisone, a derived pyridopyrimidine, and xerosin on pneumonia produced in mice by viral and bacterial toxin.

Authors:  R M DOUGHERTY; V GROUPE; R A MANAKER
Journal:  J Bacteriol       Date:  1956-11       Impact factor: 3.490

8.  Mechanism of production of pulmonary lesions in mice by Newcastle disease virus (NDV).

Authors:  H S GINSBERG
Journal:  J Exp Med       Date:  1951-09       Impact factor: 14.307

Review 9.  Pneumonia virus of mice: severe respiratory infection in a natural host.

Authors:  Helene F Rosenberg; Joseph B Domachowske
Journal:  Immunol Lett       Date:  2008-04-22       Impact factor: 3.685

10.  Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus).

Authors:  G A Prince; D D Porter; A B Jenson; R L Horswood; R M Chanock; H S Ginsberg
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.